MedCity New reports on a study by A.T. Kearney that has some interesting findings for medical device design:
The analysts say that the “emerging markets will save us” theory is false. Executives they interviewed have not figured out how to make the “Western” approach work in other parts of the world. The report suggests that companies target “less affluent segments that can offer significant absolute profit potential with the right solutions” in traditional markets. Making money from Americans who now have health insurance for the first time “will require new business models, lower price points, and more value-based product offerings than those of today.”
A.T. Kearney estimates that there is a latent 10% growth rate for medical devices if companies can tap this new market segment. You can read the full report here .